149 related articles for article (PubMed ID: 19419197)
1. Development of a genetically engineered biomimetic vector for targeted gene transfer to breast cancer cells.
Mangipudi SS; Canine BF; Wang Y; Hatefi A
Mol Pharm; 2009; 6(4):1100-9. PubMed ID: 19419197
[TBL] [Abstract][Full Text] [Related]
2. A designer biomimetic vector with a chimeric architecture for targeted gene transfer.
Wang Y; Mangipudi SS; Canine BF; Hatefi A
J Control Release; 2009 Jul; 137(1):46-53. PubMed ID: 19303038
[TBL] [Abstract][Full Text] [Related]
3. Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells.
Canine BF; Wang Y; Hatefi A
J Control Release; 2009 Sep; 138(3):188-96. PubMed ID: 19379785
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel histone H1-based recombinant fusion peptide for targeted non-viral gene delivery.
Soltani F; Sankian M; Hatefi A; Ramezani M
Int J Pharm; 2013 Jan; 441(1-2):307-15. PubMed ID: 23200954
[TBL] [Abstract][Full Text] [Related]
5. D-SP5 Peptide-Modified Highly Branched Polyethylenimine for Gene Therapy of Gastric Adenocarcinoma.
Li X; Xie Z; Xie C; Lu W; Gao C; Ren H; Ying M; Wei X; Gao J; Su B; Ren Y; Liu M
Bioconjug Chem; 2015 Aug; 26(8):1494-503. PubMed ID: 26052814
[TBL] [Abstract][Full Text] [Related]
6. Design, engineering and preparation of a multi-domain fusion vector for gene delivery.
Sadeghian F; Hosseinkhani S; Alizadeh A; Hatefi A
Int J Pharm; 2012 May; 427(2):393-9. PubMed ID: 22342333
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the interactions of adenovirus-derived peptides with plasmid DNA and their role in gene delivery mediated by liposome-peptide-DNA virus-like nanoparticles.
Preuss M; Tecle M; Shah I; Matthews DA; Miller AD
Org Biomol Chem; 2003 Jul; 1(14):2430-8. PubMed ID: 12956058
[TBL] [Abstract][Full Text] [Related]
8. Breathing New Life into TRAIL for Breast Cancer Therapy: Co-Delivery of pTRAIL and Complementary siRNAs Using Lipopolymers.
Thapa B; Kc R; Bahniuk M; Schmitke J; Hitt M; Lavasanifar A; Kutsch O; Seol DW; Uludag H
Hum Gene Ther; 2019 Dec; 30(12):1531-1546. PubMed ID: 31547718
[TBL] [Abstract][Full Text] [Related]
9. A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma.
Chen K; Cao X; Li M; Su Y; Li H; Xie M; Zhang Z; Gao H; Xu X; Han Y; Zhou J; Wang W
Theranostics; 2019; 9(10):2984-2998. PubMed ID: 31244937
[TBL] [Abstract][Full Text] [Related]
10. TRAIL-secreting human mesenchymal stem cells engineered by a non-viral vector and photochemical internalization for pancreatic cancer gene therapy.
Han J; Hwang HS; Na K
Biomaterials; 2018 Nov; 182():259-268. PubMed ID: 30142525
[TBL] [Abstract][Full Text] [Related]
11. A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.
Sova P; Ren XW; Ni S; Bernt KM; Mi J; Kiviat N; Lieber A
Mol Ther; 2004 Apr; 9(4):496-509. PubMed ID: 15093180
[TBL] [Abstract][Full Text] [Related]
12. Development of recombinant biomimetic nano-carrier for targeted gene transfer to HER3 positive breast cancer.
Nazari M; Minai-Tehrani A; Mousavi S; Zamani Koukhaloo S; Emamzadeh R
Int J Biol Macromol; 2021 Oct; 189():948-955. PubMed ID: 34455002
[TBL] [Abstract][Full Text] [Related]
13. Assessment of CAR- or CD46-dependent adenoviral vector-mediated TRAIL gene therapy in clinical adenocarcinoma lung cancer cells.
Wang Y; Ma L; Wang S; Bao Y; Ni C; Guan N; Zhao J; Fan X
Oncology; 2009; 77(6):366-77. PubMed ID: 20068366
[TBL] [Abstract][Full Text] [Related]
14. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide mu and plasmid DNA.
Tagawa T; Manvell M; Brown N; Keller M; Perouzel E; Murray KD; Harbottle RP; Tecle M; Booy F; Brahimi-Horn MC; Coutelle C; Lemoine NR; Alton EW; Miller AD
Gene Ther; 2002 May; 9(9):564-76. PubMed ID: 11973632
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer by adenovirus-mimetic peptides in the presence of a cationic lipid and/or adenovirus. Analysis of the contribution of the viral and nonviral components.
Moritz S; Colin M; Keller M; Klonjkowski B; Capeau J; Coutelle C; Chroboczek J; Brahimi-Horn MC
Arch Virol; 2003 Jan; 148(1):1-18. PubMed ID: 12536292
[TBL] [Abstract][Full Text] [Related]
17. Self-assembly of an aptamer-decorated chimeric peptide nanocarrier for targeted cancer gene delivery.
Dehghani S; Alibolandi M; Tehranizadeh ZA; Oskuee RK; Nosrati R; Soltani F; Ramezani M
Colloids Surf B Biointerfaces; 2021 Dec; 208():112047. PubMed ID: 34418722
[TBL] [Abstract][Full Text] [Related]
18. Development of novel recombinant biomimetic chimeric MPG-based peptide as nanocarriers for gene delivery: Imitation of a real cargo.
Majidi A; Nikkhah M; Sadeghian F; Hosseinkhani S
Eur J Pharm Biopharm; 2016 Oct; 107():191-204. PubMed ID: 27368745
[TBL] [Abstract][Full Text] [Related]
19. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL
Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
[TBL] [Abstract][Full Text] [Related]
20. Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases.
Zafir-Lavie I; Sherbo S; Goltsman H; Badinter F; Yeini E; Ofek P; Miari R; Tal O; Liran A; Shatil T; Krispel S; Shapir N; Neil GA; Benhar I; Panet A; Satchi-Fainaro R
J Control Release; 2018 Dec; 291():80-89. PubMed ID: 30342077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
